Zydus Lifesciences Q1 Results Net Income Up to ₹1,419.90 Crores

Zydus Lifesciences Growth Comparison

Zydus Lifesciences has shared its financial results for the first quarter of the fiscal year 2024 (Q1 FY24). The total revenue for this quarter was ₹6,207.50 crores, which shows a strong increase compared to ₹5,139.60 crores in the same quarter last year (YoY). This increase demonstrates good growth for the company year-over-year (YoY). When comparing the current quarter to the previous quarter (QoQ), revenue rose from ₹4,667.70 crores to ₹6,207.50 crores, reflecting a strong quarter-on-quarter (QoQ) performance.

Zydus Lifesciences’ Net Income also improved significantly, reaching ₹1,419.90 crores in Q1 FY24, up from ₹1,086.90 crores last year (YoY). This growth shows that Zydus Lifesciences is becoming more profitable year-over-year (YoY). When we look at the previous quarter's net income of ₹296.60 crores, the increase is impressive, indicating a positive trend in the company's financial health on a quarter-on-quarter (QoQ) basis. The diluted normalized earnings per share (EPS) also increased from ₹10.87 last year to ₹14.11 this year (YoY), reflecting the company’s strong performance. Overall, Zydus Lifesciences is showing significant growth both year-over-year (YoY) and quarter-on-quarter (QoQ).

Here are the quarterly results for Zydus Lifesciences for Q1 FY24, presented in a simple and clear table format:

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results

Zydus Lifesciences Q1 Results 

Zydus Lifesciences earned INR 41,602 million, an increase from INR 33,324 million in the previous quarter for the quarter ending June 30, 2024. They also made an additional INR 1,066 million from other income, leading to a total income of INR 42,668 million.

Zydus Lifesciences spends money on various things like materials, employee salaries, and other costs. Total expenses were INR 22,335 million, which is an increase from INR 16,935 million last quarter. After subtracting expenses from total income, Zydus Lifesciences made a profit of INR 20,333 million before taxes. After accounting for taxes, the net profit for the quarter was INR 17,006 million. The company's earnings per share also increased to INR 16.90. 

Here’s a summarized version of the standalone unaudited financial results for the quarter ended June 30, 2024, structured for clarity:

(Rs. in millions)

Zydus Lifesciences Stock Performance

Zydus Lifesciences is a company with a market capitalization of ₹1,05,720 crore, indicating its total value in the stock market. The current stock price is ₹1,051. It has reached a high of ₹1,324 and a low of ₹568 in the past year, showing some price fluctuation. The Price-to-Earnings (P/E) ratio is 25.4, which helps investors understand how much they are paying for each unit of profit. The book value is ₹197, indicating the company's net asset value per share. Zydus Lifesciences offers a dividend yield of 0.29%, meaning shareholders receive a small percentage of profits. 

Here's a summary of the financial information you provided, presented in a clear table format:

Quarterly Results 

Zydus Lifesciences showed strong financial performance in its quarterly results for December 2023, March 2024, and June 2024. In December 2023, the company reported sales of 4,505 crores, which increased to 5,534 crores in March 2024 and further to 6,208 crores in June 2024. 

Here’s the quarterly results summary focusing on December 2023, March 2024, and June 2024:

(Consolidated Figures in Rs. Crores)

About Zydus Lifesciences

Zydus Lifesciences is a healthcare company that has evolved from its previous name, Cadila Healthcare. The company has over 70 years of experience in the healthcare industry and is committed to improving people's lives through innovative solutions. Zydus Lifesciences focuses on creating medicines and healthcare products that meet the needs of patients and caregivers. Their mission is to provide quality healthcare that is accessible to everyone. The company has a strong dedication to science and research, which helps them develop new treatments and technologies.

Zydus Lifesciences values inclusivity and believes that its success comes from the collaboration of its employees, patients, partners, and investors. The new logo and brand colors represent this commitment to care and community. Zydus Lifesciences aims to be a dynamic and patient-centered organization that leads the way in healthcare innovation.